Kiromic BioPharma Overview
Kiromic BioPharma Discounted Cash Flow
DCF Analysis for KRBP.
Get informed when a big investor buys or sells
+ FollowFair Value
$-0.61
Current Fair Value
$-0.61
↓ 851.9% Downside
Overvalued by 851.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison